Table Of Contents:
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. Premature Ejaculation Market: By Treatment Type Market Trends, Size, and Future Outlook
- By Treatment Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Treatment Type Definitions, Technology Landscape
- By Treatment Type Market Drivers
- Product Launches
- Technology Launches
- By Treatment Type Market Restraints
- Chapter 4. Premature Ejaculation Market: By Distribution Channel Market Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Distribution Channel Definitions, Technology Landscape
- By Distribution Channel Market Drivers
- Product Launches
- Technology Launches
- By Distribution Channel Market Restraints
- Chapter 5. Premature Ejaculation Market: By Age Group Market Trends, Size, and Future Outlook
- By Age Group Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Age Group Definitions, Technology Landscape
- By Age Group Market Drivers
- Product Launches
- Technology Launches
- By Age Group Market Restraints
- Chapter 6. Premature Ejaculation Market: By End User Market Trends, Size, and Future Outlook
- By End User Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By End User Definitions, Technology Landscape
- By End User Market Drivers
- Product Launches
- Technology Launches
- By End User Market Restraints
- Chapter 7. Premature Ejaculation Market: By Cause Market Trends, Size, and Future Outlook
- By Cause Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Cause Definitions, Technology Landscape
- By Cause Market Drivers
- Product Launches
- Technology Launches
- By Cause Market Restraints
- Chapter 8. Premature Ejaculation Market: By Severity Market Trends, Size, and Future Outlook
- By Severity Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Severity Definitions, Technology Landscape
- By Severity Market Drivers
- Product Launches
- Technology Launches
- By Severity Market Restraints
- Chapter 9. Premature Ejaculation Market: Regional Market Trends, Size, and Future Outlook
- North America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Europe
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Asia Pacific
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Latin America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Middle East, and Africa
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- North America
- Premature Ejaculation Market: Competitive Landscape
- Promescent (UK)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Ixcingo (Sweden)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Absorption Pharmaceuticals (US)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Plethora Solutions (UK)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Allergan (US)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Dong-A Socio Holdings (South Korea)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Metuchen Pharma (US)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Recordati (Italy)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Futura Medical (UK)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Rexana Pharm (Germany)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Promescent (UK)
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Premature Ejaculation industry is USD 2.85 billion.
Increasing awareness and destigmatization of sexual health issues, Development of new and effective treatment options, Growing prevalence of underlying conditions, Improving access to healthcare, Rising disposable incomes, Aging populations, Increasing stress levels, Favorable reimbursement policies, Expansion of online pharmacies, Increasing focus on men's health, Technological advancements in drug delivery, Growing prevalence of chronic diseases, Increasing urbanization, Changing lifestyles, Increasing healthcare expenditure.
Social stigma and cultural barriers, Lack of awareness and underreporting, Limited reimbursement and affordability concerns, Potential side effects of treatments, Regulatory hurdles, High cost of research and development, Availability of alternative therapies, Lack of skilled healthcare professionals, Stringent regulatory requirements, Limited product differentiation.
The leading component segment in the Premature Ejaculation Market is the topical treatments segment, which includes topical anesthetic sprays and creams to delay ejaculation.
The major players operating in the Premature Ejaculation Market are Promescent (UK), Ixcingo (Sweden), Absorption Pharmaceuticals (US), Plethora Solutions (UK), Allergan (US), Dong-A Socio Holdings (South Korea), Metuchen Pharma (US), Recordati (Italy), Futura Medical (UK), and Rexana Pharm (Germany).
North America is expected to lead the Premature Ejaculation Market, with a CAGR of around 12-15% and a market size of USD 1 billion by 2031.
Increasing awareness and destigmatization, Development of new treatments, Growing prevalence, Aging populations, Rising disposable incomes, Improving healthcare access, Favorable reimbursement policies, Technological advancements.